X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

iBIO Commends Illinois the Life Sciences Community for its Impact through the iBIO COVID-19 PPE Response Fund

Content Team by Content Team
7th April 2020
in News
iBIO Commends Illinois the Life Sciences Community for its Impact through the iBIO COVID-19 PPE Response Fund

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

iBIO announced that since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life sciences community is making a significant impact in the fight against the coronavirus. As of this morning, the fund has received more than $760,000 in cash contributions and thousands of donated supplies.

iBIO is directing monetary donations to its BIO Business Solutions lab supply partner, which places ongoing orders for personal protective equipment (PPE) equipment to meet the urgent needs of first responders, nurses and doctors throughout Illinois. Through this fund, iBIO has purchased

50,300 gloves
13,500 items of protective clothing
12,000 surgical masks
1,100 supplies for coronavirus testing
3,000 goggles plus other PPE items

Product donations include:

5,000 supplies for coronavirus testing
3,620 N95 masks
2,430 surgical masks
2,430 hand bottles of hand sanitizer

Purchased items are sent to the Illinois Emergency Management Agency (IEMA), which distributes the products to healthcare and emergency response systems statewide to ensure that the supply is equitable.

Starting today and continuing each Monday, iBIO is posting weekly updates on the fund and its impact.

Expansion of corporate support

On Thursday, April 2nd, Astellas Pharma US announced sponsorship of the iBIO COVID-19 PPE Response Fund as part of up to $2 million in new financial assistance, in aggregate, that Astellas and the Astellas Global Health Foundation will be providing to support patients, healthcare workers and first responders in local and global communities. Astellas is the second Illinois-based life sciences company to offer significant support to the fund, following last week’s donation from Horizon Therapeutics.

“We are grateful that a portion of Astellas’ commitment will support the iBIO COVID-19 PPE Response Fund, which will be used to purchase life-saving equipment for nurses, doctors and paramedics,” said iBIO President and CEO John Conrad. “These heroes continue to show up for battle despite the great risks to their health and to the health of their families. Thank you, Astellas.”

“With this fund and our community’s leadership, we are making an immediate impact. We ask other organizations and individuals to join Horizon and Astellas in supporting our frontline healthcare workers,” added Conrad. “Please donate unused medical products or a make a financial donation to iBIO’s COVD-19 PPE Response Fund.”

About iBIO

The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association that represents the 85,000 life sciences employees at member companies, universities, service providers and venture firms. iBIO promotes the industry’s value to the public and policymakers; connects innovators to investment and talent; stimulates collaboration and fosters the next generation of innovators and entrepreneurs to transform patient lives through groundbreaking research and works to grow the Illinois economy. For more information, please visit www.iBIO.org.

Previous Post

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development

Next Post

Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19

Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In